Ankylosing Spondylitis Research Today is a free monthly online journal that collates and summarizes the latest research about Ankylosing Spondylitis, including details on diagnosis, treatment, symptoms, causes.

Volume 2 (2005), Issue 1 (January)

1. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
   Ann Rheum Dis, 64(2): 235-8. [Abstract] [Full-text]
2. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease.
   Arthritis Rheum, 52(1): 269-74. [Abstract] [Full-text]
3. Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis.
   Ann Rheum Dis, 64(2): 229-34. [Abstract] [Full-text]
4. Open label trial of anakinra in active ankylosing spondylitis over 24 weeks.
   Ann Rheum Dis, 64(2): 296-8. [Abstract] [Full-text]
5. Comparison of early and late pleuropulmonary findings of ankylosing spondylitis by high-resolution computed tomography and effects on patients' daily life.
   Clin Rheumatol, 24(1): 22-8. [Abstract] [Full-text]
6. Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS.
   Clin Rheumatol, 24(1): 41-7. [Abstract] [Full-text]

© 2004-2008 Ankylosing Spondylitis Research Today. All Rights Reserved.